Aim: There is wide recognition that the challenge of providing health care into the future requires planning for a sustainable workforce particularly in the context of increasing service demand. The Medical Oncology Work Group (MOWG) undertook a survey of vocationally registered medical oncologists which aimed to support future workforce planning and the development of models of care.

Methods: The survey was developed and carried out by the MOWG in conjunction with the Ministry of Health during 2009. Medical oncologists were sent the survey and forwarded unnamed completed responses to one of the authors (SB).

Results: A total of 33 out of 40 practising medical oncologists completed the survey, representing an 82% response rate. The survey found that there is an emerging movement from a male-dominated workforce largely working full time, to a workforce with a higher proportion of females and part-time workers. The median full-time medical oncologist in New Zealand was responsible for 220 first specialist assessments (FSAs) per annum, 40 more than the number considered reasonable by the surveyed practitioners. In qualitative responses, medical oncologists expressed frustration with lack of resources and high workloads that constrained their ability to appropriately deploy their skills and undertake teaching and research. Positive aspects included collegial collaboration and patient contact. Prominent suggestions for improving job satisfaction included use of skilled administrative staff or nurse specialists to free up time for oncologists to better use their skills.

Conclusion: The survey highlights high clinical workload and frustration within the medical oncology workforce. In addition there is increasing service demand. This survey has formed the basis of work to develop new models of care in medical oncology.

Download full-text PDF

Source

Publication Analysis

Top Keywords

medical oncologists
20
medical oncology
12
medical
9
increasing service
8
service demand
8
survey
7
workforce
6
oncologists
6
workforce survey
4
survey zealand
4

Similar Publications

: In Romania, breast cancer is the second most common cancer, the third leading cause of cancer death, and the most prevalent cancer overall. De novo advanced-stage breast cancer often presents in clinical practice, and treatment decisions are best made in a multidisciplinary tumor board (MTD) involving surgeons, radiotherapists, and medical oncologists. Significant advances in systemic therapies, particularly in progression-free survival (PFS) and overall survival (OS), have surpassed traditional palliative mastectomy and radiotherapy for local control.

View Article and Find Full Text PDF

: The incidence and prevalence of cancers are increasing worldwide, with special emphasis placed on prevention, early detection, and the development of new therapeutic strategies that strongly impact patient outcomes. Limited data are available about emergency care's role in treating patients with cancer. This study aims to determine the burden of end-stage and first-time diagnosis of cancer on emergency care in a high-turnover emergency care center.

View Article and Find Full Text PDF

Chimeric antigen receptor T-cell (or CAR-T) therapy and bispecific antibodies (BsAbs) have revolutionized the treatment of hematologic malignancies, offering new options for relapsed or refractory cases. However, these therapies carry risks of early complications, such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), and delayed issues like graft-versus-host disease (GVHD), infections, and secondary cancers. Effective management requires early diagnosis using advanced biomarkers and imaging, along with prompt interventions involving immunosuppressants, corticosteroids, and cytokine inhibitors.

View Article and Find Full Text PDF

The landscape of available therapeutic options for treatment of genitourinary (GU) cancers is expanding dramatically. Many of these treatments have distinct, sometimes severe, skin toxicities including morbilliform, bullous, pustular, lichenoid, eczematous, psoriasiform, and palmoplantar eruptions. Pruritus and skin pigmentation changes have also been noted.

View Article and Find Full Text PDF

Purpose: The aim of this study was to compare estimates of adherence to oral endocrine therapy (OET) based on real-world data (RWD) and on clinical evaluation in people diagnosed with breast cancer in the public healthcare system in Catalonia (Spain).

Methods: We conducted two retrospective cohort studies. Cohort 1 (RWD) consisted of women diagnosed with breast cancer in 2021 in the public healthcare system of Catalonia (Spain).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!